Literature DB >> 31572522

Osteoporotic vertebral fracture caused by topical corticosteroid abuse: A case report.

Stefano Piaserico1, Dennis Linder2, Francesco Messina1, Mauro Alaibac1.   

Abstract

In the present case report, a 32-year-old man with a 20-year long history of psoriasis, who presented with severe lower back pain and had no records of previous trauma, is reported. The patient reported the regular use of clobetasol cream, for 8 years, at an average dosage of 100 grams (g) per week. At the time of visit, the patient presented with severe psoriasis, which was associated with a cushingoid appearance. An X-ray of the spine was performed and the results revealed diffuse vertebral collapse that was caused by osteoporosis. The patient was diagnosed with iatrogenic Cushing's syndrome caused by the long-term use of clobetasol 17-propionate cream. The topical clobetasol treatment was stopped and replaced with infliximab infusions. Complete control of the disease was subsequently achieved. Iatrogenic Cushing's syndrome is generally caused by systemic corticosteroid abuse. However, the topical application of potent glucocorticoids, including clobetasol treatment on the skin and mucosae, results in the same syndrome.
Copyright © 2019, Spandidos Publications.

Entities:  

Keywords:  psoriasis; topical corticosteroid; vertebral fracture

Year:  2019        PMID: 31572522      PMCID: PMC6755447          DOI: 10.3892/etm.2019.7825

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  15 in total

1.  Cushing's syndrome secondary to topical corticosteroids abuse.

Authors:  Bahri Ermis; Rahmi Ors; Ayhan Tastekin; Behzat Ozkan
Journal:  Clin Endocrinol (Oxf)       Date:  2003-06       Impact factor: 3.478

Review 2.  Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature.

Authors:  Therdpong Tempark; Voraluk Phatarakijnirund; Susheera Chatproedprai; Suttipong Watcharasindhu; Vichit Supornsilchai; Siriwan Wananukul
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

3.  Erythrodermic psoriasis associated with hyperuricemia and Iatrogenic Cushing's syndrome due to topical corticosteroid therapy.

Authors:  T Ohnishi; T Suzuki; S Watanabe; H Takahashi
Journal:  Int J Dermatol       Date:  1996-05       Impact factor: 2.736

Review 4.  Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations.

Authors:  E O Gilbertson; M C Spellman; D J Piacquadio; M I Mulford
Journal:  J Am Acad Dermatol       Date:  1998-02       Impact factor: 11.527

Review 5.  Iatrogenic Cushing's syndrome and topical steroid therapy: case series and review of the literature.

Authors:  Sem Decani; Veronica Federighi; Elisa Baruzzi; Andrea Sardella; Giovanni Lodi
Journal:  J Dermatolog Treat       Date:  2013-02-03       Impact factor: 3.359

6.  Adrenal suppression following low-dose topical clobetasol propionate.

Authors:  E M Ohman; S Rogers; F O Meenan; T J McKenna
Journal:  J R Soc Med       Date:  1987-07       Impact factor: 5.344

7.  Temporary Cushing's syndrome from percutaneous absorption of betamethasone 17-valerate.

Authors:  J A Keipert; R Kelly
Journal:  Med J Aust       Date:  1971-03-06       Impact factor: 7.738

8.  IL-17A-mediated sRANK ligand elevation involved in postmenopausal osteoporosis.

Authors:  I Molnár; I Bohaty; É Somogyiné-Vári
Journal:  Osteoporos Int       Date:  2013-12-13       Impact factor: 4.507

9.  A case of multiple bone fractures due to the use of topical corticosteroid therapy for psoriasis.

Authors:  Müzeyyen Gönül; Engin Gönül
Journal:  J Dermatolog Treat       Date:  2014-06-20       Impact factor: 3.359

10.  Iatrogenic Cushing's syndrome following short-term intranasal steroid use.

Authors:  Deep Dutta; K S Shivaprasad; Sujoy Ghosh; Satinath Mukhopadhyay; Subhankar Chowdhury
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.